Mycronic (MYCR) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
14 Jul, 2026Executive summary
Record order intake up 119% year-over-year to SEK 2,917 million, with strong contributions from all divisions, especially Global Technologies and High Volume.
Net sales rose 17% year-over-year to SEK 2,416 million, the second-highest ever, primarily driven by Global Technologies.
Gross margin improved to 57% from 53% year-over-year; EBIT increased to SEK 698 million with a margin of 29%.
Order backlog increased to SEK 5,255 million, providing solid visibility.
Financial highlights
Revenue grew 17% year-over-year to SEK 2,416 million.
Aftermarket revenue hit a record SEK 544 million, now 24% of net sales.
Rolling 12-month revenue reached SEK 8,649 million with a 26% EBIT margin.
Net cash position at quarter-end was SEK 2,267 million.
Q2 EPS: SEK 2.70 (vs. 2.28); H1 EPS: SEK 6.36 (vs. 5.46).
Outlook and guidance
Full-year 2026 net sales guidance raised to SEK 9.25 billion (from SEK 8.75 billion), reflecting strong demand and favorable currency effects.
Global Technologies EBIT margin expected to normalize around 30% as capacity investments catch up with demand.
PCB Assembly Solutions aims to restore EBIT margin to above 10% through restructuring by end of 2027.
Latest events from Mycronic
- Record sales and EBIT, but 2025 outlook narrowed due to tariff and currency uncertainty.MYCR
Q1 20259 Jul 2026 - Q4 order intake fell 19%, but annual sales and order intake hit record highs; four acquisitions made.MYCR
Q4 20258 Jul 2026 - Q2 delivered strong sales, EBIT growth, upgraded guidance, and new climate targets.MYCR
Q2 20248 Jul 2026 - Record Q1 sales and EBIT drive upgraded 2026 outlook and higher dividend proposal.MYCR
Q1 202624 Apr 2026 - Record year with double-digit growth, strong margins, and increased shareholder returns.MYCR
Q4 202417 Dec 2025 - Net sales up 40% and EBIT margin at 31%, with 2024 guidance confirmed at SEK 6.5 billion.MYCR
Q3 202414 Dec 2025 - Order intake up 67% but net sales and EBIT margin declined; 2025 outlook remains strong.MYCR
Q3 202523 Oct 2025 - Q2 net sales up 35%, order intake down, and 2025 sales guidance raised after key acquisitions.MYCR
Q2 202511 Jul 2025